华源再生

Biotech/Healthcare

Founded in 2018, Huayuan Regenerative Medicine develops bioartificial organs that can replace donor organs using human stem cell and tissue engineering technologies. The company aims to address organ shortages and extend human life with a high quality of living.

Latest round: Pre Series A Extension (2023)